Ledger.Open graph →
SEC Form D · filed May 22, 2014

Relmada Therapeutics, Inc

Offering
$15.1M
Sold
$15.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Sandesh O. Seth · New York, NYDirectorNabil M. Yazgi · New York, NYDirectorEliseo O. Salinas · New York, NYExecDouglas O. Beck · New York, NYExecShreeram O. Agharkar · New York, NYDirectorSergio Traversa · New York, NYExec · DirectorJohn S. Pennington · Sandy, UTExecRobert Baron · TUSTIN, CAExec · DirectorRandall Letcavage · TUSTIN, CADirectorWoodrow Clark Ii · TUSTIN, CAExecLane Harrison · TUSTIN, CADirectorJames R. Balkcom Jr · ATLANTA, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗